Reading this on a mobile device? Try our optimized mobile version here:

February 9, 2009
Easy networking at the BIO Exhibition. More than 2,100 companies will take advantage of the BIO Exhibition, May 18 to 21, 2009. See the exhibitor list. Make sure your company is represented.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at

  Today's Top Story 
It's no secret, biotech and pharmaceutical companies face security risks greater than those in other industries due to the value of their intellectual property. This FREE whitepaper examines the enormous cost of security breaches, the risks life sciences managers and executives introduce through common business practices, and misconceptions that jeopardize a company's most valuable assets.
  Health Care in Transition 
  • Obama vows to lift funding limits on stem cell research
    President Barack Obama said he will sign an executive order that would lift restrictions on federal funding for stem cell research. In a private discussion with House Democrats, Obama said he plans to collaborate with Congress to strengthen the order with legislation. Rep. Diana DeGette, D-Colo., said she was "encouraged" by Obama's statements and intends to work with the White House on the "two-pronged strategy." The Washington Post/44 blog (2/6) LinkedInFacebookTwitterEmail this Story
  • Kansas governor on short list for HHS chief, source says
    Kansas Gov. Kathleen Sebelius is among the top contenders on President Barack Obama's list of nominees for HHS secretary, a senior administration official said. A spokesman for the White House said Obama has not made a decision. Sebelius supported Obama's bid for the presidency and served as Kansas insurance commissioner for eight years. Yahoo!/The Associated Press (2/8) LinkedInFacebookTwitterEmail this Story
  • Bredesen also under consideration: Administration officials also said that Tennessee Gov. Phil Bredesen is under consideration for the HHS post. Other candidates may be on the list and a decision is expected soon, the officials said. Politico (Washington, D.C.) (2/9) LinkedInFacebookTwitterEmail this Story
  • Health care funding reduced in stimulus bill
    Senators are preparing to clear a version of the economic stimulus bill worth $827 billion after negotiating with the White House to slash at least $100 billion from the proposal. As a result, spending for health information technology would be reduced, and other provisions involving health care would be affected. Modern Healthcare (free registration) (2/7) LinkedInFacebookTwitterEmail this Story
Eliminate TMF Inadequacies in Your Clinical Trials
To comply with regulatory requirements pertinent to clinical trials, every organization engaged in a clinical trial must manage and maintain all trial-related content, documents, and data in a manner that not only supports the claims to the safety and efficacy of a product, but that also serves as evidence the trial was conducted in a compliant manner. Download the whitepaper.
  Health Care & Policy 
  • Study: Brain protein protects animals from Alzheimer's
    A U.S. study found that an injection of a protein called brain-derived neurotrophic factor helped boost the memory and cognitive function of laboratory animals that were older, were genetically engineered to exhibit symptoms similar to Alzheimer's disease or had damage in the entorhinal cortex. The protein, which is naturally produced by the brain, also prevented the death and degeneration of cells, researchers said. Yahoo!/HealthDay News (2/8) LinkedInFacebookTwitterEmail this Story
  • 2 gene variants provide clues on thyroid cancer
    Scientists at DeCODE Genetics found that some thyroid cancer patients with two genetic variations had lower levels of a hormone made by the pituitary gland that triggers the thyroid gland to produce its own hormones. A genetic test might not be necessary, but it could prove useful for those susceptible to thyroid cancer, said Dr. Kari Stefansson, DeCODE's CEO. (2/6) LinkedInFacebookTwitterEmail this Story
  • Study links elevated protein levels to chronic kidney disease progression
    Chronic kidney disease appears to progress faster in patients with high levels of a protein called neutrophil gelatinase-associated lipocalin in their urine and blood than in those with lower levels, Italian researchers found. The findings on the protein provide a "great new tool" for averting the progression of the condition by helping identify those who need aggressive treatment, one of the researchers said. Yahoo!/Reuters (2/6) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  • Bristol-Myers to spin off Mead Johnson Nutrition
    Bristol-Myers Squibb is taking subsidiary Mead Johnson Nutrition public to raise cash and to bolster its focus on pharmaceuticals. Bristol would still own about 87.5% of shares in Mead Johnson and hopes to secure $562.5 million from the initial public offering. Reuters (2/6) LinkedInFacebookTwitterEmail this Story
  • Other News
  Featured Content 

  Hot Topics 

Top five news stories selected by BIO SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Industrial & Environmental 
  • Vilsack: USDA starts talks with EPA to increase ethanol blend rate
    USDA Secretary Tom Vilsack said the agency has begun discussing with the Environmental Protection Agency a proposal to increase the amount of ethanol that should be mixed with gasoline, though talk so far hasn't included "specific numbers." Vilsack said it is important to seek new approaches that would help preserve the ethanol sector's infrastructure "because it is a key component" to the new energy future envisioned by President Barack Obama. Bloomberg (2/6) LinkedInFacebookTwitterEmail this Story
  News from BIO 
  • Looking for new strategies for managing your company's cash flow during this economic lull?
    Now is the time to check out BIO Business Solutions, BIO's cost-savings program. With 15 money-saving opportunities with leading providers in the biotech industry, saving your company money is made easier with BIO Business Solutions. Participation is free to members of BIO and 38 state/regional biotech associations. Get a complete list of the products and services available to you here. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

You miss 100% of the shots you never take."
--Wayne Gretzky,
Canadian professional ice hockey player

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Executive:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent BIO SmartBrief Issues:   Lead Editor:  Ashley McMaster
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005
© 1999-2011 SmartBrief, Inc.® Legal Information